Cargando…
Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
Berberine (BBR) has been demonstrated to exert cardiovascular protective effects by regulating gut microbiota. However, few studies examine the effect of BBR on the gut microbiota in hypertension. This study aims to investigate the role of BBR in regulating microbial alterations and vascular functio...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957906/ https://www.ncbi.nlm.nih.gov/pubmed/35350612 http://dx.doi.org/10.3389/fmicb.2022.814855 |
_version_ | 1784676833187332096 |
---|---|
author | Wang, Zhichao Wu, Fang Zhou, Qianbing Qiu, Yumin Zhang, Jianning Tu, Qiang Zhou, Zhe Shao, Yijia Xu, Shiyue Wang, Yan Tao, Jun |
author_facet | Wang, Zhichao Wu, Fang Zhou, Qianbing Qiu, Yumin Zhang, Jianning Tu, Qiang Zhou, Zhe Shao, Yijia Xu, Shiyue Wang, Yan Tao, Jun |
author_sort | Wang, Zhichao |
collection | PubMed |
description | Berberine (BBR) has been demonstrated to exert cardiovascular protective effects by regulating gut microbiota. However, few studies examine the effect of BBR on the gut microbiota in hypertension. This study aims to investigate the role of BBR in regulating microbial alterations and vascular function in hypertension. C57BL/6 J mice were infused with Ang II (0.8 mg/kg/day) via osmotic minipumps and treated with BBR (150 mg/kg/day) or choline (1%) for 4 weeks. Blood pressure was detected by tail-cuff measurement once a week. Abdominal aorta pulse wave velocity (PWV) and endothelium dependent vasodilatation were measured to evaluate vascular function. Vascular remodeling was assessed by histological staining of aortic tissue. The fecal microbiota was profiled using 16S ribosomal DNA (rDNA) sequencing. Plasma trimethylamine (TMA)/trimethylamine-N-oxide (TMAO) and hepatic FMO3 expression were measured. We found that BBR treatment significantly alleviated the elevated blood pressure, vascular dysfunction, and pathological remodeling in Ang II-induced hypertensive mice, while choline treatment aggravated hypertension-related vascular dysfunction. 16S rDNA gene sequencing results showed that BBR treatment altered gut microbiota composition (reduced the Firmicutes/Bacteroidetes (F/B) ratio and increased the abundances of Lactobacillus). Moreover, BBR inhibited FMO3 expression and plasma TMA/TMAO production in hypertensive mice. TMAO treatment increased the apoptosis and oxidative stress of human aortic endothelial cells (HAECs) and aggravated Ang II-induced HAECs dysfunction in vitro. These results indicate that the protective effect of BBR in hypertension might be attributed (at least partially) to the inhibition of TMAO production via regulating the gut microbiota. |
format | Online Article Text |
id | pubmed-8957906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89579062022-03-28 Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice Wang, Zhichao Wu, Fang Zhou, Qianbing Qiu, Yumin Zhang, Jianning Tu, Qiang Zhou, Zhe Shao, Yijia Xu, Shiyue Wang, Yan Tao, Jun Front Microbiol Microbiology Berberine (BBR) has been demonstrated to exert cardiovascular protective effects by regulating gut microbiota. However, few studies examine the effect of BBR on the gut microbiota in hypertension. This study aims to investigate the role of BBR in regulating microbial alterations and vascular function in hypertension. C57BL/6 J mice were infused with Ang II (0.8 mg/kg/day) via osmotic minipumps and treated with BBR (150 mg/kg/day) or choline (1%) for 4 weeks. Blood pressure was detected by tail-cuff measurement once a week. Abdominal aorta pulse wave velocity (PWV) and endothelium dependent vasodilatation were measured to evaluate vascular function. Vascular remodeling was assessed by histological staining of aortic tissue. The fecal microbiota was profiled using 16S ribosomal DNA (rDNA) sequencing. Plasma trimethylamine (TMA)/trimethylamine-N-oxide (TMAO) and hepatic FMO3 expression were measured. We found that BBR treatment significantly alleviated the elevated blood pressure, vascular dysfunction, and pathological remodeling in Ang II-induced hypertensive mice, while choline treatment aggravated hypertension-related vascular dysfunction. 16S rDNA gene sequencing results showed that BBR treatment altered gut microbiota composition (reduced the Firmicutes/Bacteroidetes (F/B) ratio and increased the abundances of Lactobacillus). Moreover, BBR inhibited FMO3 expression and plasma TMA/TMAO production in hypertensive mice. TMAO treatment increased the apoptosis and oxidative stress of human aortic endothelial cells (HAECs) and aggravated Ang II-induced HAECs dysfunction in vitro. These results indicate that the protective effect of BBR in hypertension might be attributed (at least partially) to the inhibition of TMAO production via regulating the gut microbiota. Frontiers Media S.A. 2022-03-08 /pmc/articles/PMC8957906/ /pubmed/35350612 http://dx.doi.org/10.3389/fmicb.2022.814855 Text en Copyright © 2022 Wang, Wu, Zhou, Qiu, Zhang, Tu, Zhou, Shao, Xu, Wang and Tao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Wang, Zhichao Wu, Fang Zhou, Qianbing Qiu, Yumin Zhang, Jianning Tu, Qiang Zhou, Zhe Shao, Yijia Xu, Shiyue Wang, Yan Tao, Jun Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title | Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title_full | Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title_fullStr | Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title_full_unstemmed | Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title_short | Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice |
title_sort | berberine improves vascular dysfunction by inhibiting trimethylamine-n-oxide via regulating the gut microbiota in angiotensin ii-induced hypertensive mice |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957906/ https://www.ncbi.nlm.nih.gov/pubmed/35350612 http://dx.doi.org/10.3389/fmicb.2022.814855 |
work_keys_str_mv | AT wangzhichao berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT wufang berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT zhouqianbing berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT qiuyumin berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT zhangjianning berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT tuqiang berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT zhouzhe berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT shaoyijia berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT xushiyue berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT wangyan berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice AT taojun berberineimprovesvasculardysfunctionbyinhibitingtrimethylaminenoxideviaregulatingthegutmicrobiotainangiotensiniiinducedhypertensivemice |